Protagonist Therapeutics ...
(PTGX)
undefined
undefined%
At close: undefined
41.08
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Revenue | 60.00M | 26.58M | 27.36M | 28.63M | 231.00K | 30.93M | 20.06M | - | - | - |
Cost of Revenue | - | 1.03M | 2.77M | - | - | - | - | 317.00K | 247.00K | - |
Gross Profit | 60.00M | 25.55M | 24.58M | 28.63M | 231.00K | 30.93M | 20.06M | -317.00K | -247.00K | - |
Operating Income | -93.65M | -131.37M | -125.84M | -64.52M | -80.52M | -42.27M | -37.90M | -32.67M | -14.79M | -9.32M |
Interest Income | 14.90M | 4.06M | 443.00K | 900.00K | 2.81M | 2.57M | 948.00K | 242.00K | 19.00K | 16.00K |
Pretax Income | -78.95M | -127.39M | -125.55M | -64.84M | -77.88M | -39.72M | -36.96M | -37.18M | -14.86M | -11.07M |
Net Income | -78.95M | -123.41M | -122.63M | -66.15M | -77.19M | -38.92M | -36.96M | -37.18M | -14.86M | -11.07M |
Selling & General & Admin | 33.49M | 31.74M | 27.20M | 18.64M | 15.75M | 13.70M | 11.78M | 6.96M | 2.96M | 1.86M |
Research & Development | 120.16M | 126.22M | 126.01M | 74.51M | 65.00M | 59.50M | 46.18M | 25.70M | 11.83M | 7.46M |
Other Expenses | - | -80.00K | -149.00K | -46.00K | -1K | - | - | -34.00K | - | - |
Operating Expenses | 153.65M | 157.95M | 153.20M | 93.14M | 80.75M | 73.19M | 57.96M | 32.67M | 14.79M | 9.32M |
Interest Expense | - | - | - | 598.00K | 169.00K | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 153.65M | 157.95M | 153.20M | 93.14M | 80.75M | 73.19M | 57.96M | 32.67M | 14.79M | 9.32M |
Income Tax | - | -3.98M | -2.92M | 1.30M | -691.00K | -799.00K | -406.00K | 4.16M | 64.00K | 1.75M |
Shares Outstanding (Basic) | 56.76M | 49.04M | 46.32M | 34.40M | 25.89M | 22.36M | 17.69M | 6.50M | 5.88M | 5.88M |
Shares Outstanding (Diluted) | 56.76M | 49.04M | 46.32M | 34.40M | 25.89M | 22.36M | 17.69M | 6.50M | 5.88M | 5.88M |
EPS (Basic) | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
EPS (Diluted) | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
EBITDA | -90.34M | -131.37M | -123.07M | -63.66M | -78.31M | -39.20M | -36.55M | -32.35M | -14.55M | -9.06M |
Depreciation & Amortization | 3.31M | 1.03M | 2.77M | 789.00K | 703.00K | 527.00K | 406.00K | 317.00K | 247.00K | 258.00K |